FDA advisors endorse Pfizer’s RSV vaccine for neonates, but safety concerns raised
The independent panel of advisors for the U.S. Food and Drug Administration has recommended full approval of Pfizer's vaccine for infants, which provides protection against respiratory syncytial virus (RSV). The…